Omnicell Statistics
Total Valuation
Omnicell has a market cap or net worth of $2.08 billion. The enterprise value is $2.13 billion.
Important Dates
The next estimated earnings date is Thursday, February 6, 2025, before market open.
Earnings Date | Feb 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Omnicell has 46.32 million shares outstanding. The number of shares has increased by 1.84% in one year.
Current Share Class | 46.32M |
Shares Outstanding | 46.32M |
Shares Change (YoY) | +1.84% |
Shares Change (QoQ) | +0.85% |
Owned by Insiders (%) | 1.90% |
Owned by Institutions (%) | 101.77% |
Float | 45.41M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 24.03 |
PS Ratio | 1.94 |
Forward PS | 1.77 |
PB Ratio | 1.69 |
P/TBV Ratio | 8.66 |
P/FCF Ratio | 15.62 |
P/OCF Ratio | 12.27 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 80.21, with an EV/FCF ratio of 15.95.
EV / Earnings | n/a |
EV / Sales | 2.00 |
EV / EBITDA | 80.21 |
EV / EBIT | n/a |
EV / FCF | 15.95 |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.50.
Current Ratio | 1.05 |
Quick Ratio | 0.87 |
Debt / Equity | 0.50 |
Debt / EBITDA | 16.68 |
Debt / FCF | 4.60 |
Interest Coverage | -5.39 |
Financial Efficiency
Return on equity (ROE) is -1.46% and return on invested capital (ROIC) is -1.08%.
Return on Equity (ROE) | -1.46% |
Return on Assets (ROA) | -0.87% |
Return on Capital (ROIC) | -1.08% |
Revenue Per Employee | $291,563 |
Profits Per Employee | -$4,845 |
Employee Count | 3,650 |
Asset Turnover | 0.47 |
Inventory Turnover | 5.90 |
Taxes
In the past 12 months, Omnicell has paid $1.16 million in taxes.
Income Tax | 1.16M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.01% in the last 52 weeks. The beta is 0.78, so Omnicell's price volatility has been lower than the market average.
Beta (5Y) | 0.78 |
52-Week Price Change | +17.01% |
50-Day Moving Average | 45.43 |
200-Day Moving Average | 36.34 |
Relative Strength Index (RSI) | 46.41 |
Average Volume (20 Days) | 634,170 |
Short Selling Information
The latest short interest is 2.12 million, so 4.59% of the outstanding shares have been sold short.
Short Interest | 2.12M |
Short Previous Month | 1.36M |
Short % of Shares Out | 4.59% |
Short % of Float | 4.68% |
Short Ratio (days to cover) | 2.79 |
Income Statement
In the last 12 months, Omnicell had revenue of $1.06 billion and -$17.69 million in losses. Loss per share was -$0.39.
Revenue | 1.06B |
Gross Profit | 440.97M |
Operating Income | -31.57M |
Pretax Income | -20.77M |
Net Income | -17.69M |
EBITDA | 26.52M |
EBIT | -31.57M |
Loss Per Share | -$0.39 |
Full Income Statement Balance Sheet
The company has $570.63 million in cash and $614.14 million in debt, giving a net cash position of -$43.51 million or -$0.94 per share.
Cash & Cash Equivalents | 570.63M |
Total Debt | 614.14M |
Net Cash | -43.51M |
Net Cash Per Share | -$0.94 |
Equity (Book Value) | 1.23B |
Book Value Per Share | 26.59 |
Working Capital | 49.75M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $169.82 million and capital expenditures -$36.45 million, giving a free cash flow of $133.38 million.
Operating Cash Flow | 169.82M |
Capital Expenditures | -36.45M |
Free Cash Flow | 133.38M |
FCF Per Share | $2.88 |
Full Cash Flow Statement Margins
Gross margin is 41.44%, with operating and profit margins of -2.97% and -1.66%.
Gross Margin | 41.44% |
Operating Margin | -2.97% |
Pretax Margin | -1.55% |
Profit Margin | -1.66% |
EBITDA Margin | 2.49% |
EBIT Margin | -2.97% |
FCF Margin | 12.53% |
Dividends & Yields
Omnicell does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.84% |
Shareholder Yield | -1.84% |
Earnings Yield | -0.85% |
FCF Yield | 6.40% |
Dividend Details Analyst Forecast
The average price target for Omnicell is $52.00, which is 15.61% higher than the current price. The consensus rating is "Buy".
Price Target | $52.00 |
Price Target Difference | 15.61% |
Analyst Consensus | Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | 11.94% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Omnicell has an Altman Z-Score of 1.52 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.52 |
Piotroski F-Score | 2 |